Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma

(2018) Wanyong Chen et al.   Journal of Cancer

Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating interleukin-8 expression

(2017) Yanfeng Liu et al.   HEPATOLOGY

Programmed cell death-1 (PD-1) checkpoint blockade in combination with a mammalian target of rapamycin inhibitor restrains hepatocellular carcinoma growth induced by hepatoma cell-intrinsic PD-1

(2017) Hui Li et al.   HEPATOLOGY

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma

(2017) Thai Huu Ho et al.   JOURNAL OF CLINICAL ONCOLOGY

Decreased WWOX expression promotes angiogenesis in osteosarcoma

(2017) Jia Wen et al.   Oncotarget

Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk

(2017) Hsiang-Lin Lee et al.   PLoS One

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

(2016) Dario Callegaro et al.   LANCET ONCOLOGY

The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis

(2016) Silvio Bandini et al.   OncoImmunology

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Ectopic WWOX Expression Inhibits Growth of 5637 Bladder Cancer Cell In Vitro and In Vivo

(2015) Gang Li et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Nomograms in oncology: more than meets the eye

(2015) Vinod P Balachandran et al.   LANCET ONCOLOGY

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

(2015) Jordi Bruix et al.   LANCET ONCOLOGY

WWOX: A fragile tumor suppressor

(2014) Morgan S Schrock et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation

(2014) Cyril Mignot et al.   JOURNAL OF MEDICAL GENETICS

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

(2013) Yizhou Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Systematic review of actual 10-year survival following resection for hepatocellular carcinoma

(2012) Annelise M. Gluer et al.   HPB

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

WWOX gene may contribute to progression of non-small-cell lung cancer (NSCLC)

(2010) Onur Baykara et al.   TUMOR BIOLOGY

Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy

(2008) Melanie B. Thomas et al.   ANNALS OF SURGICAL ONCOLOGY

Targeted Ablation of the WW Domain-Containing Oxidoreductase Tumor Suppressor Leads to Impaired Steroidogenesis

(2008) Rami I. Aqeilan et al.   ENDOCRINOLOGY

The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX

(2008) Ileana Aderca et al.   JOURNAL OF HEPATOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE